Evolus reports higher revenue and narrower loss in Q2
Evolus Q2 net revenue rose 21% to USD 84.1 million; GAAP net loss narrowed to USD 8.05 million from USD 17.14 million a year earlier.
GAAP operating loss narrowed to USD 4.5 million from USD 10.2 million; adjusted EBITDA swung to a profit of USD 4.7 million from a loss of USD 7.9 million.
Gross margin was 68%; adjusted gross profit margin was 69%, helped by a tariff refund worth about 120 basis points.
Cash and cash equivalents totaled USD 45.2 million at June 30, down from USD 49.8 million at March 31.
Raised 2026 net revenue outlook to USD 330 million-USD 337 million; expects HA gels to contribute 10%-12% of full-year revenue.
EOLS•
